Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2026-01-03 @ 10:36 PM
Study NCT ID:
NCT01072357
Status:
COMPLETED
Last Update Posted:
2018-06-15
First Post:
2010-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Efficacy of Bevacizumab in High-Risk Corneal Transplant Survival
Sponsor:
Reza Dana, MD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
09-07-062
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None